|
This report is being submitted as part of remediation activities associated with capa 643143, addressing mdr reporting guidance from the fda s 1995 preamble, which ensures complaints related to corrections and recalls previously reported to the fda under 21 cfr 806 are now reported as mdrs; this is not a new malfunction/event.Product analysis: upon receipt of the suspect complaint device at medtronic¿s quality laboratory, visual analysis showed the carriage components detached from the dcs.The device was received with the capsule fully closed.The deployment knob appeared to retract and advance the capsule.The trigger moved to fully advanced and retracted positions and locked in place when released.The tip-retrieval mechanism appeared intact.The device was returned with the end cap/screw gear snap fit connected.The capsule appeared intact with no evidence of damage.The inner member shaft and spindle hub appeared intact with no evidence of damage.The actuator components separated during the retraction of the capsule.Both tab 3 and tab 4 of the male actuator component had a hairline crack at the point where the tab protrudes from the component.The carriage components were observed to be undamaged.Conclusion: the device history record was reviewed and showed this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.The subject dcs was returned for analysis.The actuator components separated during retraction of the capsule, confirming the reported event.The carriage components were also observed to be detached, most likely due to the actuator no longer securing the carriage components in place.The snap fit tabs of the actuator were observed to be damaged.Actuator separation is typically associated with broken or damaged snap fit tabs, either one tab or both, which hold the handle together.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, while loading the valve, the blue handle of the delivery catheter system (dcs) broke apart.The paddles had just been covered and the tech began rolling the valve closed.The handle was able to be snapped back together.The dcs was not used and a new dcs was used for implant.No adverse patient effects were reported.
|